Don't believe hype about robot prostatectomy: study

NEW YORK (Reuters Health) -

Older men considering robotic surgery for prostate cancer shouldn't trust the rosy ads promoting the expensive technology over low-tech surgery.


That's according to a new survey that found complaints about sexual problems and urinary leakage were equally common after the two procedures.
"I wasn't surprised at all," said Dr. Otis Brawley, chief medical officer of the American Cancer Society, who wasn't involved in the study.
"Unfortunately, robotic prostatectomy -- like many things in prostate cancer -- has gotten a lot more hype than it should."

Read the full Reuters reporter here:Don't believe hype about robot prostatectomy

PSA screening doesn't prevent cancer deaths: study

NEW YORK (Reuters Health) -

Annual screening for prostate cancer doesn't cut men's chances of dying from the disease, according to the latest results of a large screening trial.

The results support a previous report by the same researchers that found no difference in deaths seven to 10 years after the screening program started.

They are also consistent with recent draft guidelines from the U.S. Preventive Services Task Force recommending that average-risk men not undergo regular PSA screening, according to a researcher who worked on the study.

Read the full Reuters report here

PSA screening doesn't prevent cancer deaths